Eiman Ibrahim Zaki

Eiman Ibrahim Zaki

Auto-generated profile, based on publicly available information

Eiman Ibrahim Zaki

Department of Histology and Cell Biology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SRSalma El-Sayed Radwan
Salma El-Sayed Radwan
AEAmal H El-Kamel
Amal H El-Kamel
EZEiman I Zaki
Eiman I Zaki
Susi BurgalassiSusi Burgalassi
Susi Burgalassi
EZErica Zucchetti
Erica Zucchetti
RERiham El-Moslemany
Riham El-Moslemany
Purpose: Apatinib (Apa) is a novel anti-vascular endothelial growth factor with the potential to treat diabetic retinopathy (DR); a serious condition leading to visual impairment and blindness. DR treatment relies on invasive techniques associated with various complications. Investigating topical routes for Apa delivery to the posterior eye segment is thus promising but also challenging due to ocular barriers. Hence, the study objective was to develop Apa-loaded bovine serum albumin nanoparticles (Apa-BSA-NPs) coated with hyaluronic acid (HA); a natural polymer possessing unique mucoadhesive and viscoelastic features with the capacity to actively target CD44 positive retinal cells, for topical administration in DR. Methods: Apa-BSA-NPs were prepared by desolvation using glutaraldehyde for cross-linking. HA-coated BSA-NPs were also prepared and HA: NPs ratio optimized. Nanoparticles were characterized for colloidal properties, entrapment efficiency (EE%), in vitro drug release and mucoadhesive potential. In vitro cytotoxicity on rabbit corneal epithelial cells (RCE) was assessed using MTT assay, while efficacy was evaluated in vivo in a diabetic rat model by histopathological examination of the retina by light and transmission electron microscopy. Retinal accumulation of fluorescently labeled BSA-NP and HA-BSA-NP was assessed using confocal microscope scanning. Results: Apa-HA-BSA-NPs prepared under optimal conditions showed size, PdI and zeta potential: 222.2± 3.56 nm, 0.221± 0.02 and − 37.3± 1.8 mV, respectively. High EE% (69± 1%), biphasic sustained release profile with an initial burst effect and mucoadhesion was attained. No evidence of cytotoxicity was observed on RCE cells. In vivo histopathological studies on DR rat model revealed alleviated retinal micro- and ultrastructural changes in the topical HA-Apa-BSA-NP treated eyes with normal basement membrane and retinal thickness comparable to normal control and intravitreally injected nanoparticles. Improved retinal accumulation for HA-BSA-NP was also observed by confocal microscopy. Conclusion: Findings present HA-Apa-BSA-NPs as a platform for enhanced topical therapy of DR overcoming the devastating ocular complications of the intravitreal route.

21 September 2018 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
NANaglaa Fathi Agamia
Naglaa Fathi Agamia
OROsama Hussein Roshdy
Osama Hussein Roshdy
RARania ElSaied Abdelmaksoud
Rania ElSaied Abdelmaksoud
DADina Mohamed Abdalla
Dina Mohamed Abdalla
Iman Mamdouh (M.) TalaatIman Mamdouh (M.) Talaat
Iman Mamdouh (M.) Talaat
Bodo MelnikBodo Melnik
Bodo Melnik

11 November 2025 in Reproductive Toxicology
Verified
Journal Article
Closed access
SASarah E. Amin
Sarah E. Amin
EFEman F. Farghaly
Eman F. Farghaly
DADoaa A. Abdelmonsif
Doaa A. Abdelmonsif
EZEiman I. Zaki
Eiman I. Zaki
WOWalaa Omar
Walaa Omar

30 June 2019 in Cellular and Molecular Biology
Verified
Journal Article
Closed access
PDF file
EZEiman I. Zaki
Eiman I. Zaki
AEAyman S. El-Seedy
Ayman S. El-Seedy
IKInaam P. Kelada
Inaam P. Kelada
NSNadia A. Sharafeldin
Nadia A. Sharafeldin
HMHala M. Abdel Mouaty
Hala M. Abdel Mouaty
HRHeba S. Ramadan
Heba S. Ramadan
The present study aimed to disclose the histological alterations and cyto-genotoxic potential induced by citrate- and chitosan-capped AuNPs on liver of adult Swiss albino mice. Animals were randomly divided into 8 groups. The first two groups were intraperitoneally (i.p) injected with physiological saline once and left for 10 days and every other day for 21 days, respectively, and kept as negative control groups. While the third and fourth groups were injected i.p with a single dose of 2 mg/kg of citrate- and chitosan-capped AuNPs, respectively, and left for 10 days. The fifth and sixth groups were injected i.p every other day for 21 days with 200 µg/kg of citrate- and chitosan-capped AuNPs, respectively. Animals of the seventh and eighth groups were injected i.p with 50 mg/kg cyclophosphamide once and left for 10 days and with 20 mg/kg cyclophosphamide every other day for 21 days, respectively. The livers of mice were dissected and processed for microscopic examination and for analyzing the expression of inflammation-related genes using RT-PCR. In addition, bone marrow samples were taken to investigate the mitotic index and the chromosomal aberrations. The present study showed various degrees of structural changes in the liver of animals received AuNPs. Such changes were more prominent in animals treated with a single dose of AuNPs, particularly with citrate-capped AuNPs as compared to chitosan-capped AuNPs. Furthermore, genotoxic analysis did not reveal any genotoxicity for AuNPs with both coats. Therefore, chitosan-capped AuNPs were less hepatotoxic than citrate-capped ones. However, it has not been proven that AuNPs are genotoxic by both coats.

22 March 2022 in Egyptian Journal of Histology
Verified
Journal Article
Closed access
AAAhmed Elsaeed Ayad
Ahmed Elsaeed Ayad
AHAdel Mostafa Hussein
Adel Mostafa Hussein
FAFerial Fathy Ali
Ferial Fathy Ali
AKAyman Ahmed Khanfor
Ayman Ahmed Khanfor
EZEiman Ibrahim Zaki
Eiman Ibrahim Zaki
Background: The placenta act as barrier that protects the embryo against injurious agents. Aspartame, an artificial sweetener used throughout the world, its metabolites can cross the placenta and cause change on its structure. Ginger is a plant used in the treatment of vomiting during pregnancy. Its extracts were reported to have an antioxidant action.Aim of the Work: Assessing the histopathological and the teratogenic effect of Aspartame on the placenta and fetuses of albino rat and study the possible protective effect of Ginger.Materials and Methods: Fifty female albino rats were divided into four groups: Control group: received distilled water. Aspartame group received 265 mg/kg body weight (b.w) Aspartame, Ginger group received 200 mg/kg b.w Ginger extract and Aspartame-Ginger group received 265mg/kg b.w Aspartame then 200 mg/kg b.w Ginger extract by orogastric tube on gestational days from one to 18. Placenta weighted and processed for histological examination and immunohistochemical staining to detect vascular endothelial growth factor (VEGF) expression. Fetuses were weighted and examined for anomalies.Results: Aspartame group showed a significant a decrease in the mean maternal weight gain, placental weight, fetal weight and length. Additionally, a decreased basal zone and an increased labyrinth zone thickness were detected. Moreover, this group showed placental structure alternations on the light and the electron microscopic level, an increase in the intehemal membrane thickness and a significant increase in the VEGF expression in the labyrinth zone. Ginger improved all fetal and maternal parameters and ameliorated the Aspartame induced effect on the placenta. Conclusion: Aspartame has a deleterious effect on albino rat’s placenta fetus, adding Ginger ameliorate this impact.

30 March 2021 in Egyptian Journal of Histology
Verified
Journal Article
Open access
SKSalma Hany Kandiel
Salma Hany Kandiel
TATarek Abd El-Azim Abd Allah
Tarek Abd El-Azim Abd Allah
WHWafaa Ahmed Hewedy
Wafaa Ahmed Hewedy
HMHazem Farag Mannaa
Hazem Farag Mannaa
EZEiman Ibrahim Zaki
Eiman Ibrahim Zaki
Background: Diabetes mellitus (DM) is a worldwide health problem affecting a population of different ages, which inflicts a large economic load on the worldwide health-care system. This disease is mostly characterized by hyperglycemia which causes deleterious effects on both the macro- and microvasculature. Pharmacological treatment includes many drugs with different mechanisms of action. These drugs aim to control the hyperglycemic state and subsequently may protect the vessels from its deleterious effect.Aim of the work: The aim of our study is to compare the potential protective effect of three of these antidiabetic drugs; Acarbose, Linagliptin and Quercetin, on the aorta of type 2 diabetes mellitus rat model. Materials and methods: Forty male albino rats were divided into 5 groups. Two control groups; normal control group (normal group) and diabetic control group (DM group). Diabetes was induced by feeding rats with high-fat diet (HFD) for 2 weeks followed by a single dose Streptozotocin (STZ) injection. Three diabetic groups received different treatments; diabetic group treated with Acarbose (DM+AC group), diabetic group treated with Linagliptin (DM+LN group) and diabetic group treated with Quercetin (DM+QR group). Blood samples were taken for biochemical evaluation and specimens of the aorta were taken for histological and morphometric analysis.Results: Diabetic group showed histological findings recorded in atherosclerotic aorta. The three tested antidiabetic drugs Acarbose, Linagliptin and Quercetin, showed an ameliorative effect on the structure of the aorta but no noticeable differences were recorded.Conclusion: Our study revealed that the changes produced in the structure of the aorta of the diabetic group were ameliorated in the groups received the three drugs with no noticeable differences between them.